We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCB icon
3026
Coastal Financial
CCB
$623M
$185K ﹤0.01%
12,110
ICBK
3027
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$185K ﹤0.01%
10,600
SURF
3028
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$183K ﹤0.01%
43,082
+9,136
+27% +$70.5K
ESTE
3029
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$183K ﹤0.01%
40,403
NYNY
3030
DELISTED
Empire Resorts, Inc.
NYNY
$182K ﹤0.01%
17,924
-304
-2% -$2.92K
RAIL icon
3031
FreightCar America
RAIL
$265M
$179K ﹤0.01%
26,610
+1,910
+8% +$21.7K
AKAO
3032
DELISTED
Achaogen Inc
AKAO
$178K ﹤0.01%
144,342
-2,964
-2% -$7.91K
MNTX
3033
DELISTED
Manitex International, Inc.
MNTX
$177K ﹤0.01%
31,069
TTPH
3034
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$176K ﹤0.01%
7,776
+1,965
+34% +$76.8K
GYRE icon
3035
Gyre Therapeutics
GYRE
$635M
$175K ﹤0.01%
2,947
MLP icon
3036
Maui Land & Pineapple Co
MLP
$352M
$175K ﹤0.01%
17,559
ROX
3037
DELISTED
Castle Brands, Inc.
ROX
$172K ﹤0.01%
201,300
+43,150
+27% +$39.7K
HNRG icon
3038
Hallador Energy
HNRG
$673M
$170K ﹤0.01%
33,360
+5,260
+19% +$30.8K
COGT icon
3039
Cogent Biosciences
COGT
$6.7B
$169K ﹤0.01%
+9,548
New +$283K
XOMA
3040
DELISTED
Xoma
XOMA
$169K ﹤0.01%
13,350
-25,896
-66% -$370K
LOGC
3041
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$169K ﹤0.01%
+16,200
New +$196K
DRRX
3042
DELISTED
DURECT Corp
DRRX
$166K ﹤0.01%
34,316
-13,340
-28% -$116K
ACMR icon
3043
ACM Research
ACMR
$5.51B
$164K ﹤0.01%
45,000
SB icon
3044
Safe Bulkers
SB
$795M
$164K ﹤0.01%
91,780
-5,820
-6% -$13.2K
YARW
3045
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$158K ﹤0.01%
11
CUE icon
3046
Cue Biopharma
CUE
$111M
$156K ﹤0.01%
1,103
IBRX icon
3047
ImmunityBio
IBRX
$7.59B
$156K ﹤0.01%
133,777
-2,584
-2% -$5.91K
NEOS
3048
DELISTED
Neos Therapeutics, Inc
NEOS
$156K ﹤0.01%
94,530
+38,330
+68% +$108K
QHC
3049
DELISTED
Quorum Health Corporation
QHC
$155K ﹤0.01%
53,300
DZSI
3050
DELISTED
DZS Inc. Common Stock
DZSI
$154K ﹤0.01%
11,000

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.